JPMORGAN CHASE & CO - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,083,470
+121.1%
40,500
+123.8%
0.00%
+100.0%
Q2 2023$6,369,571
+193.0%
18,100
+162.3%
0.00%
Q1 2023$2,174,000
+13562.6%
6,900
-87.5%
0.00%
-100.0%
Q4 2022$15,912
-99.9%
55,100
+7.2%
0.00%0.0%
Q3 2022$14,882,000
+2.7%
51,4000.0%0.00%0.0%
Q2 2022$14,484,000
+270.0%
51,400
+242.7%
0.00%
Q1 2022$3,915,000
+3459.1%
15,000
+2900.0%
0.00%
Q4 2021$110,000
+20.9%
5000.0%0.00%
Q3 2021$91,000
-9.9%
5000.0%0.00%
Q2 2021$101,000
-99.9%
500
-99.8%
0.00%
-100.0%
Q1 2021$69,861,000
+501.6%
325,100
+712.8%
0.01%
+350.0%
Q2 2020$11,612,000
-42.5%
40,000
-52.8%
0.00%
-60.0%
Q1 2020$20,178,000
+181.0%
84,800
+158.5%
0.01%
+400.0%
Q4 2019$7,182,000
+96.3%
32,800
+51.9%
0.00%0.0%
Q3 2019$3,659,000
+60.1%
21,600
+68.8%
0.00%
Q2 2019$2,286,000
-91.1%
12,800
-90.8%
0.00%
-100.0%
Q1 2019$25,679,000
+641.5%
139,600
+567.9%
0.01%
+400.0%
Q4 2018$3,463,000
-29.5%
20,900
-18.0%
0.00%0.0%
Q3 2018$4,915,000
-56.6%
25,500
-61.7%
0.00%
-50.0%
Q2 2018$11,319,000
+30.1%
66,600
+24.7%
0.00%0.0%
Q1 2018$8,703,000
+741.7%
53,400
+673.9%
0.00%
Q4 2017$1,034,000
+6.3%
6,900
+6.2%
0.00%
Q3 2017$973,000
-86.8%
6,500
-90.4%
0.00%
-100.0%
Q1 2017$7,381,000
+238.6%
67,500
+170.0%
0.00%
+100.0%
Q3 2016$2,180,00025,0000.00%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
WINTRUST INVESTMENTS LLC 2,700$492,0000.05%
GROUP ONE TRADING, L.P. 153,800$40,137,0000.04%
SG Americas Securities, LLC 100,500$3,032,0000.02%
SIMPLEX TRADING, LLC 69,500$18,137,0000.02%
IMC-Chicago, LLC 18,200$4,750,0000.01%
HRT FINANCIAL LP 900$234,0000.00%
Allianz Asset Management GmbH 800$209,0000.00%
JPMORGAN CHASE & CO 15,000$3,915,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders